News

cobas_4800_system crop1000
Assays that detect hepatitis C, hepatitis C genotyping, and human immunodeficiency virus are now commercially available in countries accepting the CE mark.
All Cologuard tests are processed at the Exact Sciences lab in Madison, Wisc.
Cologuard is designed to be patient- and physician-friendly, and is highly automated to support efficiencies in Exact Sciences' lab.
_Cancer_cells2
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Photo McDade Ralph crop640
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Idex product line crop640
Idex Health & Science has launched a newly expanded portfolio of fluidic, microfluidic, and optical components and capabilities.
Four transplant centers are participating in an early access program for the company’s blood test for kidney transplant recipients.
Thermo ImmunoCAP1 crop640
The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.
Cepheid GeneXpert crop640
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
Yuling Luo, PhD, Advanced Cell Diagnostics.
In partnership with biopharmaceutical companies, Leica Biosystems and Advanced Cell Diagnostics are collaborating to develop and commercialize fully automated RNAscope-based companion diagnostics.
Nawana
With the acquisition, Abbott gains leadership in the $5.5 billion point-of-care segment, broadens its diagnostics footprint, and enhances access to fast-growing diagnostics channels.
Nanostring nCounter PanCancer profiles
This month's Product News includes focused gene expression panels, a cystatin C assay, a supply and procedure cart system, and a modular embedding system.
Campbell
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Robert Nelsen, Arch Venture Partners.
Named Grail, the business seeks to enable early cancer detection via blood-based screening.
The companies have partnered to develop a comprehensive next-generation sequencing workflow for single-cell analyses.
GenomeDx Biosciences recently presented first validation data supporting the use of its Decipher test to help guide the treatment of men newly diagnosed with prostate cancer.
Ericsson
Acquisition gives PE access to an innovative noninvasive prenatal testing solution under development, expanding the company’s maternal–fetal health portfolio.
MassSpecFlowWd
Lab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Quotient MosaiQ consumable crop640
The company reports that clinical trials using its MosaiQ transfusion diagnostic instrument and associated assays will begin later this year.
Photo BarthelemyNicolas 20141007
After closing $32 million in private equity financing, molecular diagnostics unit bioTheranostics will operate as an independent company.
The Minicare I-20 system from Philips.
Royal Philips and Banyan Biomarkers have entered into a multiyear agreement to jointly develop and commercialize a handheld blood test for detecting and evaluating mild traumatic brain injury.